Company News
Biogen Pharmachechem Q1 FY26 Results Board Meeting
• Biogen Pharmachechem intimated BSE of its upcoming board meeting on August 5, 2026.
• The board will consider and approve un-audited financial results for Q1 FY26 ended June 30, 2026.
• The disclosu